Skip to content
OpenCapital
Get started

Zimmer Biomet Holdings ZBH EPS (Basic)

EPS (Basic) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.300.0%
Stryker logo
StrykerSYK
$1.95+14.0%
PDE
Pro-Dex, Inc.PDEX
$1.23+23.0%
CONMED logo
CONMEDCNMD
$0.45+137%
Vericel logo
VericelVCEL
-$0.12+47.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$0.32-45.5%

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.81B-6.2%
Enterprise value$24.86B-4.4%
P/E23.4×+0.3×
P/S2.1×-0.3×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's EPS (basic)?
Zimmer Biomet Holdings (ZBH) reported EPS (basic) of $1.22 in Q1 2026.
How has Zimmer Biomet Holdings's EPS (basic) changed year-over-year?
Zimmer Biomet Holdings's EPS (basic) increased by 32.6% year-over-year, from $0.92 to $1.22.
What is the long-term trend for Zimmer Biomet Holdings's EPS (basic)?
Over 2 years (2023 to 2025), Zimmer Biomet Holdings's EPS (basic) has grown at a -14.7% compound annual growth rate (CAGR), from $4.91 to $3.57.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.